CAI - Caris Life Sciences, Inc.

18.59
-0.630   -3.389%

Share volume: 1,772,937
Last Updated: 03-06-2026
Healthcare/Services – Health: -0.04%

PREVIOUS CLOSE
CHG
CHG%
$19.22
-0.63
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
63%
Profitability 82%
Dept financing 29%
Liquidity 75%
Performance 50%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-4.08%
1 Month
-16.67%
3 Months
-34.45%
6 Months
-46.60%
1 Year
-33.61%
2 Year
-33.61%
Key data
Stock price
$18.59
P/E Ratio 
N/A
DAY RANGE
$18.48 - $19.26
EPS 
$0.09
52 WEEK RANGE
$17.15 - $42.50
52 WEEK CHANGE
-$33.61
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$2,711,044
AVERAGE 30 VOLUME 
$2,264,312
Company detail
CEO: David D. Halbert
Region: US
Website: www.carislifesciences.com
Employees: 1,769
IPO year: 2025
Issue type:
Market: XNAS
Industry: Healthcare/Services – Health
Sector: Services

We are a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer. We develop and commercialize innovative solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Our principal executive offices are located in Irving, Texas.

Recent news